A DOSE RISING STUDY OF THE SAFETY AND EFFECTS ON SERUM PROLACTIN OF SK-AND-F-101468, A NOVEL DOPAMINE-D2-RECEPTOR AGONIST

被引:17
作者
ACTON, G
BROOM, C
机构
关键词
D O I
10.1111/j.1365-2125.1989.tb03524.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:435 / 441
页数:7
相关论文
共 30 条
[1]  
BIRKMAYER W, 1961, Wien Klin Wochenschr, V73, P787
[2]   AREA POSTREMA - CHEMORECEPTOR TRIGGER ZONE FOR VOMITING - IS THAT ALL [J].
BORISON, HL .
LIFE SCIENCES, 1974, 14 (10) :1807-1817
[3]  
BROOM C, 1988, BR J CLIN PHARM, V26, P654
[4]  
CARLSON HE, 1983, J CLIN ENDOCR METAB, V57, P334, DOI 10.1210/jcem-57-2-334
[5]   CLASSIFICATION OF DRUGS ACCORDING TO RECEPTOR-BINDING PROFILES [J].
CLOSSE, A ;
FRICK, W ;
DRAVID, A ;
BOLLIGER, G ;
HAUSER, D ;
SAUTER, A ;
TOBLER, HJ .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1984, 327 (02) :95-101
[6]   METABOLIC-CLEARANCE AND PRODUCTION-RATES OF PROLACTIN IN MAN [J].
COOPER, DS ;
RIDGWAY, EC ;
KLIMAN, B ;
KJELLBERG, RN ;
MALOOF, F .
JOURNAL OF CLINICAL INVESTIGATION, 1979, 64 (06) :1669-1680
[7]  
FENELL WH, 1983, CIRCULATION, V67, P829
[8]   EFFECTIVENESS OF PERGOLIDE MESYLATE IN LONG-TERM TREATMENT OF HYPERPROLACTINEMIA [J].
FRANKS, S ;
HORROCKS, PM ;
LYNCH, SS ;
BUTT, WR ;
LONDON, DR .
BRITISH MEDICAL JOURNAL, 1983, 286 (6372) :1177-1179
[9]   4-[2-(DI-NORMAL-PROPYLAMINO)ETHYL]-2(3H)-INDOLONE - A PREJUNCTIONAL DOPAMINE RECEPTOR AGONIST [J].
GALLAGHER, G ;
LAVANCHY, PG ;
WILSON, JW ;
HIEBLE, JP ;
DEMARINIS, RM .
JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (10) :1533-1536
[10]  
GIBSON A, 1979, J PHARM PHARMACOL, V31, P826, DOI 10.1111/j.2042-7158.1979.tb13674.x